Published online Nov 16, 2021. doi: 10.12998/wjcc.v9.i32.9770
Peer-review started: May 25, 2021
First decision: July 3, 2021
Revised: July 13, 2021
Accepted: September 22, 2021
Article in press: September 22, 2021
Published online: November 16, 2021
Processing time: 169 Days and 0.2 Hours
Advances in radiological imaging techniques have enabled us to understand the details of biliary tract cancer (BTC) preoperatively. However, detecting small liver metastasis or peritoneal metastasis remains difficult in BTCs.
Staging laparoscopy may help avoid unnecessary laparotomy due to the occult metastases. However, there are no standard methods for selecting staging laparoscopy in BTC.
This study aimed to elucidate the risk factors for exploratory laparotomy due to occult metastasis in patients with BTC using tumor markers and inflammation-based prognostic scores.
This was a retrospective study from the data of 236 BTC patients.
Twenty-six (11%) patients underwent exploratory laparotomy, and there were sixteen occult metastasis cases (7 liver metastasis and 9 abdominal disseminations). Serum carcinoembryonic antigen, carbohydrate antigen 19-9, neutrophil-lymphocyte ratio and modified Glasgow prognostic score were significantly higher in the exploratory laparotomy group (n = 26) than in the resected group (n = 210). Among these factors, carcinoembryonic antigen > 7 ng/mL was the most useful to predict occult metastasis. When patients had more than three of these positive factors, the rate of occult metastasis increased.
Inflammation-based prognostic scores and tumor markers are useful in detecting occult metastasis in patients with BTC, and based on a combination of these factors, selective staging laparoscopy may reduce the rate of exploratory laparotomy.
Since BTCs are heterogeneous malignancies, a study with a large number of tumors is required.
